HLA-class I Markers and Multiple Sclerosis Susceptibility in the Italian Population

Overview

Journal Genes Immun

Date 2009 Nov 13

PMID 19907433

Citations 19

Authors

L Bergamaschi

M A Leone

M E Fasano

F R Guerini

D Ferrante

E Bolognesi

N Barizzone

L Corrado

P Naldi

C Agliardi

E Dametto

M Salvetti

A Visconti

D Galimberti

E Scarpini

M Vercellino

R Bergamaschi

F Monaco

D Caputo

P Momigliano-Richiardi

S DAlfonso

Affiliations

Soon will be listed here.

Abstract

Previous studies reported an association with multiple sclerosis (MS) of distinct HLA-class I markers, namely HLA-A*02, HLA-Cw*05 and MOG-142L. In this work, we tested the association with MS of A*02 and Cw*05 in 1273 Italian MS patients and 1075 matched controls, which were previously analyzed for MOG-142, and explored the relationship among these three markers in modulating MS risk. HLA-A*02 conferred a statistically robust MS protection (odds ratio, OR=0.61; 95% confidence intervals, CI=0.51-0.72, P<10(-9)), which was independent of DRB1*15 and of any other DRB1* allele and remained similar after accounting for the other two analyzed class I markers. Conversely, the protective effect we previously observed for MOG-142L was secondary to its linkage disequilibrium with A*02. Cw*05 was not associated considering the whole sample, but its presence significantly enhanced the protection in the HLA-A*02-positive group, independently of DRB1: the OR conferred by A*02 in Cw*05-positive individuals (0.22, 95% CI=0.13-0.38) was significantly lower than in Cw*05-negative individuals (0.69, 95% CI=0.58-0.83) with a significant (P=4.94 x 10(-5)) multiplicative interaction between the two markers. In the absence of A*02, Cw*05 behaved as a risk factor, particularly in combination with DRB1*03 (OR=3.89, P=0.0006), indicating that Cw*05 might be a marker of protective or risk haplotypes, respectively.

Citing Articles

Machine Learning Methods for Classifying Multiple Sclerosis and Alzheimer's Disease Using Genomic Data.

Arnal Segura M, Bini G, Krithara A, Paliouras G, Tartaglia G Int J Mol Sci. 2025; 26(5).

PMID: 40076709 PMC: 11900513. DOI: 10.3390/ijms26052085.

Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco.

Fguirouche A, Ouahmani F, Brahim I, Hazime R, Louhab N, Kissani N Clin Pract. 2025; 15(1).

PMID: 39851793 PMC: 11763420. DOI: 10.3390/clinpract15010010.

Myeloid antigen-presenting cells in neurodegenerative diseases: a focus on classical and non-classical MHC molecules.

Afify R, Lipsius K, Wyatt-Johnson S, Brutkiewicz R Front Neurosci. 2024; 18:1488382.

PMID: 39720231 PMC: 11667120. DOI: 10.3389/fnins.2024.1488382.

Variable patterns of retrotransposition in different HeLa strains provide mechanistic insights into SINE RNA mobilization processes.

Moldovan J, Kopera H, Liu Y, Garcia-Canadas M, Catalina P, Leone P Nucleic Acids Res. 2024; 52(13):7761-7779.

PMID: 38850156 PMC: 11260458. DOI: 10.1093/nar/gkae448.

High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility.

Osoegawa K, Creary L, Montero-Martin G, Mallempati K, Gangavarapu S, Caillier S Front Immunol. 2021; 12:644838.

PMID: 34211458 PMC: 8240666. DOI: 10.3389/fimmu.2021.644838.

References

Brynedal B, Duvefelt K, Jonasdottir G, Roos I, Akesson E, Palmgren J . HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS One. 2007; 2(7):e664. PMC: 1919434. DOI: 10.1371/journal.pone.0000664. View

Ballerini C, Guerini F, Rombola G, Rosati E, Massacesi L, Ferrante P . HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol. 2004; 150(1-2):178-85. DOI: 10.1016/j.jneuroim.2004.01.015. View

Cattley S, Williamson J, Tay G, Martinez O, Gaudieri S, Dawkins R . Further characterization of MHC haplotypes demonstrates conservation telomeric of HLA-A: update of the 4AOH and 10IHW cell panels. Eur J Immunogenet. 2000; 27(5-6):397-426. DOI: 10.1046/j.1365-2370.2000.00226.x. View

Thananchai H, Gillespie G, Martin M, Bashirova A, Yawata N, Yawata M . Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol. 2006; 178(1):33-7. DOI: 10.4049/jimmunol.178.1.33. View

Ebers G . Environmental factors and multiple sclerosis. Lancet Neurol. 2008; 7(3):268-77. DOI: 10.1016/S1474-4422(08)70042-5. View

Olerup O, Hillert J . HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 1991; 38(1):1-15. DOI: 10.1111/j.1399-0039.1991.tb02029.x. View

Alper C, Larsen C, Dubey D, Awdeh Z, Fici D, Yunis E . The haplotype structure of the human major histocompatibility complex. Hum Immunol. 2006; 67(1-2):73-84. DOI: 10.1016/j.humimm.2005.11.006. View

Yeo T, De Jager P, Gregory S, Barcellos L, Walton A, Goris A . A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol. 2007; 61(3):228-36. PMC: 2737610. DOI: 10.1002/ana.21063. View

Bolognesi E, Karell K, Percopo S, Coto I, Greco L, Mantovani V . Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens. 2003; 61(4):308-16. DOI: 10.1034/j.1399-0039.2003.00028.x. View

10.

DAlfonso S, Bolognesi E, Guerini F, Barizzone N, Bocca S, Ferrante D . A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun. 2007; 9(1):7-15. DOI: 10.1038/sj.gene.6364437. View

11.

Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O . Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens. 2000; 55(2):140-8. DOI: 10.1034/j.1399-0039.2000.550205.x. View

12.

Horton R, Gibson R, Coggill P, Miretti M, Allcock R, Almeida J . Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics. 2008; 60(1):1-18. PMC: 2206249. DOI: 10.1007/s00251-007-0262-2. View

13.

Dudbridge F . Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol. 2003; 25(2):115-21. DOI: 10.1002/gepi.10252. View

14.

Lincoln M, Montpetit A, Cader M, Saarela J, Dyment D, Tiislar M . A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet. 2005; 37(10):1108-12. DOI: 10.1038/ng1647. View

15.

Chao M, Barnardo M, Lui G, Lincoln M, Ramagopalan S, Herrera B . Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium. Hum Mol Genet. 2007; 16(16):1951-8. DOI: 10.1093/hmg/ddm142. View

16.

Howson J, Walker N, Clayton D, Todd J . Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab. 2009; 11 Suppl 1:31-45. PMC: 2779837. DOI: 10.1111/j.1463-1326.2008.01001.x. View

17.

Barcellos L, Sawcer S, Ramsay P, Baranzini S, Thomson G, Briggs F . Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006; 15(18):2813-24. DOI: 10.1093/hmg/ddl223. View

18.

Lublin F, Reingold S . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996; 46(4):907-11. DOI: 10.1212/wnl.46.4.907. View

19.

Compston A, Coles A . Multiple sclerosis. Lancet. 2008; 372(9648):1502-17. DOI: 10.1016/S0140-6736(08)61620-7. View

20.

Eike M, Becker T, Humphreys K, Olsson M, Lie B . Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B. Genes Immun. 2008; 10(1):56-67. DOI: 10.1038/gene.2008.74. View